The experimental small molecule drug miridesap very effectively, potently and safely, depletes SAP from the blood and thereby removes all SAP from the CSF in AD patients and from its binding to cerebral deposits of human Aβ amyloid in transgenic AD model mice. This evidence concerns the gene APCS and Alzheimer disease.